- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01708681
Lean Seafood Intake and Postprandial Metabolism (LeSIP)
October 5, 2015 updated by: National Institute of Nutrition and Seafood Research, Norway
Ability of a Lean Seafood Diet to Modulate Postprandial Metabolism in Human-beings - a Controlled Intervention Study With Cross-over Design
Despite numerous studies of meal components in humans, little is still known about how different meals influence on metabolism. The purpose of this study is to a gain knowledge of how a balanced test meal with either lean seafood (example:cod) or meat as the main protein source will:
- affect the postprandial metabolism acutely (test-meal at beginning of the study)
- affect the postprandial metabolism after 4 weeks controlled intervention (test meal at end of intervention period)
- affect gut microbiota composition
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
27
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bergen, Norway, 5005
- National Institute of Nutrition and Seafood Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18-65 years of age
- Caucasian
Exclusion Criteria:
- Smoking
- Diabetes
- Hysterectomy
- Abnormal bleeding last 6 months
- Use of medication that affects lipid and glucose metabolism
- Large (>10%) alteration in body-weight the last 6 months
- Chronic, metabolic or acute disease or major surgery within last 3 months
- Dietary incompatibility with calcium supplementation and/ or seafood consumption (allergy, intolerance, dislike)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Lean seafood
Cross-over design, half of the subject will receive lean seafood in study period I and the other half in study period II
|
|
|
Active Comparator: Meat, egg, milk
Cross-over design, half of the subject will receive meat, egg, milk in study period I and the other half in study period II
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Postprandial lipid measurement
Time Frame: Change from baseline at 4 weeks
|
Change from baseline at 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Postprandial glucose measurement
Time Frame: Change from baseline at 4 weeks
|
Change from baseline at 4 weeks
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Postprandial metabolomic measurement
Time Frame: Change from baseline at 4 weeks
|
Change from baseline at 4 weeks
|
|
Gut microbiota composition
Time Frame: Change from baseline at 4 weeks
|
Change from baseline at 4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Bjørn Liaset, Dr, NIFES
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Aadland EK, Graff IE, Lavigne C, Eng O, Paquette M, Holthe A, Mellgren G, Madsen L, Jacques H, Liaset B. Lean Seafood Intake Reduces Postprandial C-peptide and Lactate Concentrations in Healthy Adults in a Randomized Controlled Trial with a Crossover Design. J Nutr. 2016 May;146(5):1027-34. doi: 10.3945/jn.115.229278. Epub 2016 Apr 20.
- Aadland EK, Lavigne C, Graff IE, Eng O, Paquette M, Holthe A, Mellgren G, Jacques H, Liaset B. Lean-seafood intake reduces cardiovascular lipid risk factors in healthy subjects: results from a randomized controlled trial with a crossover design. Am J Clin Nutr. 2015 Sep;102(3):582-92. doi: 10.3945/ajcn.115.112086. Epub 2015 Jul 29.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2012
Primary Completion (Actual)
May 1, 2013
Study Completion (Actual)
September 1, 2015
Study Registration Dates
First Submitted
October 11, 2012
First Submitted That Met QC Criteria
October 15, 2012
First Posted (Estimate)
October 17, 2012
Study Record Updates
Last Update Posted (Estimate)
October 6, 2015
Last Update Submitted That Met QC Criteria
October 5, 2015
Last Verified
October 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NIFES-001
- 2012/1084/REK vest (Other Grant/Funding Number: NRC-200515/I30)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glucose Metabolism Disorders
-
University of AberdeenCompletedMetabolism Disorder, GlucoseUnited Kingdom
-
Columbia UniversityCompletedMetabolism Disorder, GlucoseUnited States
-
RenJi HospitalGuangdong Provincial People's Hospital; Shanghai First Maternity and Infant... and other collaboratorsEnrolling by invitationPCOS | IVF Outcome | Glucose Metabolism DisorderChina
-
University of PlymouthRecruitingGlucose Metabolism Disorders (Including Diabetes Mellitus)United Kingdom
-
University of LeipzigInstitut für Gesundheits- und Praxismanagement GmbHWithdrawn
-
Purdue UniversityAlmond Board of CaliforniaActive, not recruitingGlucose Intolerance | Glucose Metabolism Disorders (Including Diabetes Mellitus)United States
-
University of Missouri-ColumbiaCompletedGlucose | Blood Sugar; High | Glucose Metabolism Disorders (Including Diabetes Mellitus)United States
-
Solvay PharmaceuticalsCompletedDyslipidemia/Glucose Metabolism DisorderPoland, Ukraine, United Kingdom
-
Solvay PharmaceuticalsTerminatedDyslipidemia | Glucose Metabolism DisorderPoland, Croatia, Finland, France, Germany, Netherlands, Romania, Ukraine
-
University of South CarolinaCompletedPhysical Activity | Sedentary Lifestyle | Metabolism Disorder, GlucoseUnited States
Clinical Trials on Lean seafood
-
National Institute of Nutrition and Seafood Research...Ludwig-Maximilians - University of Munich; NORCE Norwegian Research Centre ASCompleted
-
University of BergenBergen Medical Research Foundation; Skretting ASA; Leroy Seafood Group ASACompletedObesity | Metabolic DisordersNorway
-
Mansoura UniversityCompleted
-
Kocaeli UniversityCompleted
-
University of Missouri-ColumbiaRecruitingDiet InterventionUnited States
-
University of Illinois at Urbana-ChampaignCompleted
-
Yale UniversityCompletedObesity | Breast Cancer SurvivorshipUnited States
-
George Mason UniversityRecruiting
-
University of JazanCompletedLow Back Pain, MechanicalSaudi Arabia
-
University of BergenBergen Medical Research Foundation; Skretting ASA; Leroy Seafood Group ASACompletedObesity | OverweightNorway